Citadel Advisors
AEMD icon

Citadel Advisors’s Aethlon Medical AEMD Stock Holding History

Citadel Advisors’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed -$116K – 13708
2021
Q3 		$116K Buy
+8
New +$134K ﹤0.01% 12684

Other funds holding AEMD

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors's AEMD Position: Q2 2026 in Review

Citadel Advisors opened a new position in Aethlon Medical (AEMD) in Q2 2026: 8,595 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #13263 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in AEMD as recently as Q3 2025.

Citadel Advisors first reported a position in AEMD in Q2 2019 and has held it in 7 quarters since. The position peaked at $72K in Q3 2022. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

  • Citadel Advisors held 8,595 shares of Aethlon Medical worth $35.4K as of Q2 2026.
  • Aethlon Medical was a new Citadel Advisors position in Q2 2026.
  • Aethlon Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13263 holding.
  • Citadel Advisors first reported a position in Aethlon Medical in Q2 2019 and has held it in 7 quarters since.
  • Citadel Advisors's Aethlon Medical position peaked at $72K in Q3 2022.
  • 15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.